EOM Pharmaceutical Holdings Provides an Update on Its Lead Drug Candidate EOM613
EOM Pharmaceutical Holdings Announces Topline Results of Its COVID-19 Clinical Trial of EOM613 in Brazil
IPO Roundup: Richtech Robotics, Triller and More
EOM Pharmaceuticals Shelves Plans to Uplist Shares, Raise $15M
EOM PHARMACEUTICAL HOLDINGS, INC. ANNOUNCES NAME CHANGE FROM IMMUNOCELLULAR THERAPEUTICS, LTD.
EOM Pharmaceuticals files to uplist to Nasdaq
Press Release: EOM Pharmaceuticals, Inc. And Immunocellular Therapeutics, Ltd. Announce Entry Into And Close Of Definitive Merger Agreement
ImmunoCellular Therapeutics L, Inst Holders, 3Q 2019 (IMUC)
ImmunoCellular Therapeutics L, Inst Holders, 2Q 2019 (IMUC)
ImmunoCellular Therapeutics L, Inst Holders, 1Q 2019 (IMUC)
ImmunoCellular Therapeutics L, Inst Holders, 4Q 2018 (IMUC)
DJ ImmunoCellular Therapeutics L, Inst Holders, 3Q 2018 (IMUC)
DJ ImmunoCellular Therapeutics Ltd. (IMUC) Halted
BRIEF-Immunocellular Therapeutics Ltd - Anthony Gringeri Resigs From Board And As President And CEO Of Co
DJ ImmunoCellular Files 8K - Director, Officer or Compensation Filing >IMUC
*DJ ImmunoCellular Therapeutics Announces Delisting and Deregistration of Common Stk and Listed Common Stk Warrants
BRIEF-ImmunoCellular Therapeutics Says Has Been Exploring Strategic Opportunities
*DJ ImmunoCellular 2Q Loss/Shr 1c >IMUC
Press Release: ImmunoCellular Therapeutics -2-
DJ ImmunoCellular Therapeutics Ltd, Inst Holders, 2Q 2018 (IMUC)
No Data